BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

994 related articles for article (PubMed ID: 11027571)

  • 21. Expression patterns of retinoblastoma and E2F family proteins during corneal development.
    Francesconi CM; Hutcheon AE; Chung EH; Dalbone AC; Joyce NC; Zieske JD
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1054-62. PubMed ID: 10752941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in E2F DNA-binding activity during induced erythroid differentiation.
    Richon VM; Venta-Perez G
    Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions.
    Lind EF; Wayne J; Wang QZ; Staeva T; Stolzer A; Petrie HT
    J Immunol; 1999 May; 162(9):5374-9. PubMed ID: 10228014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.
    Cao L; Faha B; Dembski M; Tsai LH; Harlow E; Dyson N
    Nature; 1992 Jan; 355(6356):176-9. PubMed ID: 1530885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation.
    Corbeil HB; Whyte P; Branton PE
    Oncogene; 1995 Sep; 11(5):909-20. PubMed ID: 7675450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
    Ahmad N; Gupta S; Mukhtar H
    Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor suppressor proteins as regulators of cell differentiation.
    Li ZR; Hromchak R; Mudipalli A; Bloch A
    Cancer Res; 1998 Oct; 58(19):4282-7. PubMed ID: 9766653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels.
    Jiang H; Karnezis AN; Tao M; Guida PM; Zhu L
    Oncogene; 2000 Aug; 19(34):3878-87. PubMed ID: 10951581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth.
    Smith EJ; Leone G; Nevins JR
    Cell Growth Differ; 1998 Apr; 9(4):297-303. PubMed ID: 9563849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
    Kastner A; Espanel X; Brun G
    Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus.
    Zini N; Trimarchi C; Claudio PP; Stiegler P; Marinelli F; Maltarello MC; La Sala D; De Falco G; Russo G; Ammirati G; Maraldi NM; Giordano A; Cinti C
    J Cell Physiol; 2001 Oct; 189(1):34-44. PubMed ID: 11573202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.
    Peeper DS; Keblusek P; Helin K; Toebes M; van der Eb AJ; Zantema A
    Oncogene; 1995 Jan; 10(1):39-48. PubMed ID: 7824278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E2F-independent transcriptional repression by p107, a member of the retinoblastoma family of proteins.
    Dagnino L; Zhu L; Skorecki KL; Moses HL
    Cell Growth Differ; 1995 Feb; 6(2):191-8. PubMed ID: 7756178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells.
    von Willebrand M; Zacksenhaus E; Cheng E; Glazer P; Halaban R
    Cancer Res; 2003 Mar; 63(6):1420-9. PubMed ID: 12649208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.
    Moberg K; Starz MA; Lees JA
    Mol Cell Biol; 1996 Apr; 16(4):1436-49. PubMed ID: 8657117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RBP1 induces growth arrest by repression of E2F-dependent transcription.
    Lai A; Marcellus RC; Corbeil HB; Branton PE
    Oncogene; 1999 Mar; 18(12):2091-100. PubMed ID: 10321733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
    Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
    Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD; Farlie PG; Watson RJ
    Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.